Literature DB >> 15356163

Platelet-derived thrombospondin-1 is necessary for the vitamin D-binding protein (Gc-globulin) to function as a chemotactic cofactor for C5a.

Glenda Trujillo1, Richard R Kew.   

Abstract

The chemotactic activity of C5a and C5a des Arg can be enhanced significantly by the vitamin D-binding protein (DBP), also known as Gc-globulin. DBP is a multifunctional 56-kDa plasma protein that binds and transports several diverse ligands. The objective of this study was to investigate the mechanisms by which DBP functions as a chemotactic cofactor for C5a using neutrophils and U937 cells transfected with the C5aR (U937-C5aR cells). The results demonstrate that U937-C5aR cells show C5a chemotactic enhancement only to DBP in serum, but, unlike mature neutrophils, this cell line cannot respond to DBP in plasma or to purified DBP. Analysis by SDS-PAGE and isoelectric focusing revealed no structural difference between DBP in serum compared with DBP in plasma. However, plasma supplemented with either serum, DBP-depleted serum, or activated platelet releasate provides a required factor and permits DBP to function as a chemotactic cofactor for C5a. Fractionation of activated platelet releasate revealed that the additional factor possessed the properties of thrombospondin-1 (TSP-1). Finally, purified TSP-1 alone could reproduce the effect of serum or platelet releasate, whereas Abs to TSP-1 could block these effects. These results provide clear evidence that TSP-1 is needed for DBP to function as a chemotactic cofactor for C5a. Copyright 2004 The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356163     DOI: 10.4049/jimmunol.173.6.4130

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3.

Authors:  Anisha B Shah; Stephen J DiMartino; Glenda Trujillo; Richard R Kew
Journal:  Mol Immunol       Date:  2005-08-22       Impact factor: 4.407

2.  Cofactor regulation of C5a chemotactic activity in physiological fluids. Requirement for the vitamin D binding protein, thrombospondin-1 and its receptors.

Authors:  Glenda Trujillo; Jianhua Zhang; David M Habiel; Lingyin Ge; Mahalakshmi Ramadass; Berhane Ghebrehiwet; Richard R Kew
Journal:  Mol Immunol       Date:  2011-10-19       Impact factor: 4.407

3.  Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis.

Authors:  Harald F Langer; Kyoung-Jin Chung; Valeria V Orlova; Eun Young Choi; Sunil Kaul; Michael J Kruhlak; Markella Alatsatianos; Robert A DeAngelis; Paul A Roche; Paola Magotti; Xuri Li; Matina Economopoulou; Stavros Rafail; John D Lambris; Triantafyllos Chavakis
Journal:  Blood       Date:  2010-07-12       Impact factor: 22.113

4.  Identification of two distinct cell binding sequences in the vitamin D binding protein.

Authors:  Jianhua Zhang; David M Habiel; Mahalakshmi Ramadass; Richard R Kew
Journal:  Biochim Biophys Acta       Date:  2010-03-06

5.  Neutrophil recruitment to the lung in both C5a- and CXCL1-induced alveolitis is impaired in vitamin D-binding protein-deficient mice.

Authors:  Glenda Trujillo; David M Habiel; Lingyin Ge; Mahalakshmi Ramadass; Nancy E Cooke; Richard R Kew
Journal:  J Immunol       Date:  2013-06-10       Impact factor: 5.422

6.  Bipolar disorder in youth is associated with increased levels of vitamin D-binding protein.

Authors:  Brawnie Petrov; Ayat Aldoori; Cindy James; Kefeng Yang; Guillermo Perez Algorta; Aejin Lee; Liwen Zhang; Tao Lin; Reem Al Awadhi; Jonathan R Parquette; Arpad Samogyi; L Eugene Arnold; Mary A Fristad; Barbara Gracious; Ouliana Ziouzenkova
Journal:  Transl Psychiatry       Date:  2018-03-13       Impact factor: 6.222

7.  New circulating biomarkers for predicting cardiovascular death in healthy population.

Authors:  Olle Melander; Javier Modrego; Jose J Zamorano-León; Juana M Santos-Sancho; Vicente Lahera; Antonio J López-Farré
Journal:  J Cell Mol Med       Date:  2015-08-10       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.